γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes S...

Por Morling, Joanne R., Fallowfield, Jonathan A., Williamson, Rachel M., Robertson, Christine M., Glancy, Stephen, Guha, Indra N., Strachan, Mark W. J., Price, Jackie F.
Publicado no Diabetologia (2015)

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

Por Ramachandran, Prakash, Pellicoro, Antonella, Vernon, Madeleine A., Boulter, Luke, Aucott, Rebecca L., Ali, Aysha, Hartland, Stephen N., Snowdon, Victoria K., Cappon, Andrea, Gordon-Walker, Timothy T., Williams, Mike J., Dunbar, Donald R., Manning, Jonathan R., van Rooijen, Nico, Fallowfield, Jonathan A., Forbes, Stuart J., Iredale, John P.
Publicado em 2012

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial

Por Snowdon, Victoria K., Lachlan, Neil J., Hoy, Anna M., Hadoke, Patrick W. F., Semple, Scott I., Patel, Dilip, Mungall, Will, Kendall, Timothy J., Thomson, Adrian, Lennen, Ross J., Jansen, Maurits A., Moran, Carmel M., Pellicoro, Antonella, Ramachandran, Prakash, Shaw, Isaac, Aucott, Rebecca L., Severin, Thomas, Saini, Rajnish, Pak, Judy, Yates, Denise, Dongre, Neelesh, Duffield, Jeremy S., Webb, David J., Iredale, John P., Hayes, Peter C., Fallowfield, Jonathan A.
Publicado no PLoS Med (2017)